Form 4 for TMO Thermo Fisher Scientific
Accepted 2026-04-29 16:38:18 ET · period of report 2026-04-27 · accession 0000097745-26-000089 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-04-29 16:38 | 2026-04-27 | TMO | Pettiti Gianluca | Pres, COO | S - Sale | $462.66 | -400 | 25.1K | -2% | -$185.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-04-27 | S | D | 400 | $462.66 | 25,050.83 | D | — | — | (F1) The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2025. |